Table 2.

Patient demographics by experimental group.

	Control n = 129		Intervention n = 146		Not screened N = 168		Interv v. Control	Screened v. Not Screened
	N	%	N	%	N	%	p-value	p-value
Gender							.44	.75
Male	40	31	52	35.6	57	33.7
Female	89	69	94	64.4	111	66.3
Age							.05	.2
18–24	10	7.8	24	16.4	13	7.7
25–29	6	4.7	18	12.3	22	13.1
30–39	35	27.1	41	28.1	45	26.8
40–49	31	24	26	17.8	35	20.1
50–64	33	25.6	29	19.9	40	23.8
65+	12	9.3	8	5.5	13	7.7
Race/ethnicity							.38	.04
White	43	33.3	36	24.7	26	17.3
African American	15	11.6	20	13.7	35	20.8
Hispanic/Latino	68	52.7	87	59.6	97	57.7
Other	3	2.3	3	2.1	10	6
Insurance							.13	.19
Public	74	57.4	70	48	93	55.4
Private	19	14.7	35	24	27	16
Self-pay	36	27.9	41	28	48	28.6
Patient status							.55	.38
Existing	118	91.5	130	89	144	85.7
New	11	8.5	16	11	24	14.3

Significance determined by chi-square analysis. Significant p-values at the <.05 level are in bold italics.